Editorial Board
Dr. Viswanathan is an Affiliate Scientist at the Krembil Research Institute, University Health Network, and an Assistant Professor at the Institute of Biomaterials and Biomedical Engineering, University of Toronto. Her research interest is focused on anti-inflammatory approaches to target osteoarthritis (OA), including using proprietarily-enhanced mesenchymal stromal cells (MSCs), re-programming monocytes/macrophages and using peptide inhibitors. As a clinical scientist, Dr. Viswanathan has overseen clinical translation of over 13 cell-based therapies, including as co-PI on an MSC trial to treat OA patients, a Canadian first. Dr. Viswanathan is the first editor of a recently-published book on “Mesenchymal Stromal Cells: Translational Pathways towards Clinical Adoption.
Steve Leu is currently the associate professor at Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Taiwan. His research interests include cardiomyopathy, disease animal models, stem cell-based therapy, and translational research in cardiovascular diseases.
Indranil Sinha, MD, is a Plastic Surgeon at Brigham and Women’s Hospital. Sinha earned his undergraduate degree at the University of California, Berkeley and then completed medical school training at the University of Michigan, where he was inducted into the Alpha Omega Alpha Honor Society. Dr. Sinha completed his Plastic Surgery training in the Harvard Plastic Surgery Residency Program. Dr. Sinha’s research interests include skeletal muscle stem cells and their utility in the treatment of sarcopenia and volumetric loss.
Dr. Hanson is a Reconstructive Microsurgeon and Researcher at The University of Texas MD Anderson Cancer Center with a focus on Breast Reconstruction and Lymphedema Management. She is a member of the Plastic Surgery Research Council and International Federation for Adipose Therapeutics and Science. She was recently named the American Association of Plastic Surgeons Academic Scholar. Dr. Hanson has translational research programs investigating the role of adipose derived stem cells in immunotherapy and the oncologic safety of autologous fat grafting and has published extensively on these topics.
Dr. Alessandra Pelagalliis presently working as senior Researcher in University of Naples, ITALY, Department of Advanced Biomedical Sciences in the areas of veterinary physiology. Dr. Alessandra Pelagalli worked in areas including animal platelet physiology and biochemistry. Her current interests are: role of bone mesenchymal stem cells and differentiation processes after different stimulation; role of proteins aquaporins in cell migration; role of aquaporins in permeability of different tissues in domestic animal species. Dr. Alessandra Pelagalli is corresponding author and peer reviewer of scientific papers in international journals and assistant researcher in some projects.
Dr. Kevin G. Chen obtained his medical degree from Sichuan Medical College of Sichuan University. He began his research on cancer genetics and drug resistance with Dr. Branimir Sikic at Stanford in 1993 and received his Ph.D degree in the Program of Cancer Biology at Stanford in 2002. He continued studying drug resistance mechanisms in human cancer as a postdoctoral research fellow in the Laboratory of Cell Biology, at the National Cancer Institute, NIH. In 2005, he joined the NIH Stem Cell Unit directed by Dr. Ronald McKay. Dr. Chen was appointed as Adjunct Associate Professor of Georgetown University.
Dr. Shigeo Masuda received his MD from the University of Tokyo in 1996, and PhD in Hematology/Oncology from the Graduate School of Medicine, University of Tokyo, Japan. He was an Assistant Professor and an Associate Professor at Jichi Medical University, Japan, from 2007 to 2012, and joined RIKEN CDB in 2011. He studied at the Belmonte Lab in the Salk Institute from 2012 to 2014. Currently, he is an Associate Professor of Cardiovascular Surgery in Osaka University, Japan. His interest is regenerative medicine using iPS-derived cells, including molecular targeted therapy for iPS-derived undifferentiated cells to improve safety.
Dr. Ammendola is currently a surgical oncologist and researcher. He performs translational research in collaboration with University of Strasbourg, Gothenburg, London and Ankara. He has published many original articles on international journals regarding the role of immune system in tumor angiogenesis, new biomarkers and stem cells.
Dr. Marco Tatullo is a Medicine Doctor, Ph.D and Doctor in Dental Sciences. He serves as Scientific Director of “Tecnologica Research Institute”, a private research centre focused on regenerative medicine, stem cell research and biomaterials. Adjunct Professor in “Nanomaterials in Dentistry” and Visiting Professor at the University “City Unity College” of Athens and Cyprus. Dr. Tatullo published the book “Mesenchymal Stem Cells and Innovative Biomaterials in Dentistry" with Springer-Nature. He is Guest Editor for “Stem Cell International” journal and Member of Stem Cell Italy and I.A.D.R. association. Scientific Reviewer for European grants (COST action and M-era.net) and for Austrian Science Fund (FWF) grants.
Dr. L. De Bartolo is senior research scientist at the Institute on Membrane Technology of the National Research Council of Italy and leads the research area “membrane systems in tissue engineering and regenerative medicine”. Her research is focused on bioartificial membrane systems including membrane bioreactors applied to tissue engineering and regenerative medicine. She is founding member of European and World Federation of Preventive and Regenerative Medicine (WFPRM). She is author of over 150 papers published in international journals/books and encyclopaedia and of 100 presentations to scientific meetings. She received international scientific recognitions as International Fellow by WFPRM and other awards.
Dr. Rita YH Huang is a Distinguished Professor and Director of International PhD Program for Cell Therapy and Regeneration Medicine Taipei Medical University (TMU IPCTRM) and TMU Research Center for Cell Therapy and Regeneration Medicine (TMU CCTRM). Her research interest is focused on stem cell biology, pathology, and clinical trial, covering the therapeutic potential human placenta mesenchymal stem cells, small blood stem cells, and pluripotent stem cells. Currently Dr. Huang is the Committee Board Member of Regeneration Medicine and Cell Therapy, Taiwan TFDA/MOHW (since 2014), and was invited by the review board of more than 20 international top journals.
Dr. Mustapha NAJIMI earned his doctoral degree from Université Pierre & Marie Curie. He is a Senior Research Associate at the laboratory of Pediatric Hepatology & Cell Therapy, part of the Experimental and Clinical Research Institute, Université catholique de Louvain. His main research is focused on hepatic stem cell's biology, liver regeneration and on the design of innovative cell therapy strategies for liver disease treatments. Dr. NAJIMI was member of the founding team of Promethera Biosciences, a spin-off of the Université Catholique de Louvain (for which he is currently a special adviser-scientific affairs and a member of the scientific board).
Esmaiel Jabbari completed his PhD at Purdue University and postdoctoral studies at Monsanto, Rice University, and Mayo Clinic. He is Full Professor of Chemical and Biomedical Engineering and Director of Biomaterials and Tissue Engineering at University of South Carolina. He is internationally known for his work on synthesis and processing of cell-responsive biomaterials for regenerative medicine. He received the Berton Rahn Award from AO Foundation in 2012 and the Stephen Milam Award from OMSF in 2008. He was elected to the College of Fellows of AIMBE in 2013. He has published >230 scientific articles, presented >260 seminars, and mentored >130 scholars.
Alireza Karimi received the MSc and Ph.D degree in Mechanical Engineering/Bioengineering from the Iran University of Science and Technology and Kyushu University. His primary area of interest is continuum mechanics, soft tissue mechanics, finite element modeling, injury biomechanics, and biomathematics. He also won the Nightingale prize from the International Federation for Medical and Biological Engineering (IFMBE) in 2015. He is the author of more than 110 peer reviewed articles in the international scientific journals.
Dr. Anthony Atala is the Director of Wake Forest Institute for Regenerative Medicine at Wake Forest School of Medicine. He is a practicing surgeon and a researcher in the area of regenerative medicine. In 2011 he was elected to the Institute of Medicine of the National Academy of Sciences. Over 10 applications of technologies developed in his laboratory have been used clinically. He is the editor of 20 books, has published over 400 journal articles, and has applied for or received over 200 national and international patents.
Dr. Camussi is currently Director of PhD program in Medical Pathophysiology and Full Professor and Chair of Nephrology at the University of Torino, Italy. Dr. Camussi is also Adjunct Professor of Medicine at Brown University (Ri). He is the Head of a Stem Cell Laboratory at the Molecular Biotechnology Center (MBC) and of the Laboratory of Vascular Biology and Angiogenesis at the Research Center for Experimental Medicine (CeRMS) at the University of Torino. He has been appointed as Research Associate Professor in Microbiology and Pathology at the State University of New York at Buffalo (NY) and subsequently as Full Professor of Nephrology at the University of Naples, at the University of Pavia and Director of the Department of Internal Medicine at the University of Torino. He lists over 489 publications on PubMED indexed journals dealing on mediators of inflammation, renal and lung immunopathology, neoangiogenesis, transplantation and stem cell biology.
Dr. Chen obtained a PhD degree in Biology from Northwestern University, Evanston, Illinois, the United States in 2004. After completing his postdoctoral training at Harvard University from 2005 to 2008, he moved back to China and set up his laboratory at Nankai University, Tianjin, in 2008. He is currently a Professor of Cell Biology in the College of Life Sciences. The goal of the research in Chen laboratory is to understand the molecular mechanism underlying pluripotency maintenance and differentiation of embryonic stem cells, as well as early embryogenesis. Dr. Chen has published more than 30 scientific publications.
Dr. Garbuzova-Davis earned a Ph.D.in Biological Science from Kharkiv State University, Ukraine and a Doctor of Science degree from the Ukraine National Academy of Sciences in Kiev. Dr. Garbuzova-Davis is currently a professor at the University of South Florida’s Center of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair. She performs translational research concentrating on development of cell therapies for Amyotrophic Lateral Sclerosis, stroke, and other neurological diseases. A current focus is investigation of disease related blood-CNS barrier damage and cell-based approaches for barrier repair. Dr. Garbuzova-Davis has more than 100 scientific publications and is a named inventor on 8 issued patents.
Yohei Hayashi is an assistant professor at Faculty of Medicine, University of Tsukuba. His research focuses on fundamental molecular biology on the reprogramming into pluripotent stem cells and disease modeling using human pluripotent stem cells. His major model system is induced pluripotent (iPS) cells that are engineered to test the role of specific genetic changes on disease and pluripotency. His expertise in the field of stem cell biology, genomics, and developmental biology is essential for the success of his research projects.
David Israeli is a research scientist in Genethon, which is a non-for profit research institute affiliated to the French association of muscular dystrophy (AFM). Dr Israeli is focused on pathophysiological mechanisms of muscular dystrophies with a particular interest on the Duchene muscular dystrophy (DMD) disease.
Dr. Noma obtained a doctorate (Ph.D.) in Medicine from Kyoto University.
Currently Dr. Noma is a Professor of the Department of Molecular Biology, Institute of Biomedical Sciences, Tokushima University Graduate School.
His expertise are functional genomics, metabolic regulation and regenerative biology.
He has published more than 100 scientific publications. Dr. Noma is currently a member of editorial board of the journal ‘Current Regenerative Medicine’ (formerly ‘Recent Patents on Regenerative Medicine’).
Professor, Rei Ogawa has the M.D. and Ph.D. degrees. He is currently a faculty member at the Nippon Medical School in Tokyo. He is a fellow of American College of Surgeons. He is now directing the Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School, Tokyo, Japan. He is also directing Mechanobiology and Mechanotherapy Laboratory at his medical school. He joined the Tissue Engineering and Wound Healing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA, where he worked between 2007 and 2009 as a Research Fellow. He has focused his recent studies on the mechanobiology and its application to tissue engineering, wound healing and anti-aging medicine.
Jerome Roncalli, MD, PhD completed his medical research training in Feinberg Cardiovascular Research Institute at Northwestern University in Chicago, under Professor Douglas Losordo.
Prof. Roncalli serves as Director of the Heart Failure Unit in the Department of Cardiology at the University Hospital of Toulouse, France. He also serves as the Assistant Director of the Cardiac Catheterization Laboratory since 2008. Prof. Roncalli is a member of the French and the European Society of Cardiology. His major research is focused in interventional cardiology, heart failure, tissue repair/ regeneration, angiogenesis/vasculogenesis and progenitor/ adult stem cells.
He is currently a Professor of Cardiology at the Purpan School of Medicine and coordinator of the CARDIOMET Institute in Toulouse.
Dr. Kiminobu Sugaya (Ph.D.) is a professor of medicine in Burnett School of Biomedical Science, College of Medicine, University of Central Florida (UCF). He is a Chair of Multidisciplinary Neuroscience Alliance in UCF and a Chair of Central Florida Chapter of Society for Neuroscience. He published more than 200 papers and some of them were reported by Washington Post, BBC, NBC, ABC and other media in all over the world.
Dr. Sugaya is also a founder and a chair of Progenicyte, which is a biotech company holding his 67 patent licensed from UCF.
